title: Safety of conventional drugs and biologic agents for Rheumatoid Arthritis.
abstract: While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents had decreased symptoms with those receiving traditional treatment, safety of the drugs remains a concern. The authors in this paper review the safety of the RA new therapeutic approach utilizing biological agents and compare it with the safety of conventional disease-modifying anti-rheumatic drugs (DMARDs).
authors.affiliation: Dpt. of Clinical Medicine, University of Rome La Sapienza, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Amoroso
authors.forename: A
authors.initials: A
authors.lastname: Gigante
authors.forename: C
authors.initials: C
authors.lastname: Gianni
authors.forename: D
authors.initials: D
authors.lastname: Amoroso
authors.forename: D
authors.initials: D
authors.lastname: Zennaro
authors.forename: S
authors.initials: S
authors.lastname: Galluzzo
authors.forename: D
authors.initials: D
authors.lastname: Caccavo
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007155:Immunologic Factors